Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Vet Microbiol ; 189: 15-23, 2016 Jun 30.
Article in English | MEDLINE | ID: mdl-27259822

ABSTRACT

Information on equine infectious anaemia (EIA) in mules, including those with an equivocal reaction in agar gel immunodiffusion test (AGIDT), is scarce. For this, a study was conducted to evaluate the clinical, viral loads and pathological findings of two groups of naturally infected asymptomatic mules, respectively with a negative/equivocal and positive AGIDT reactivity, which were subjected to pharmacological immune suppression (IS). A non-infected control was included in the study that remained negative during the observation period. Throughout the whole study, even repeated episodes of recrudescence of EIA were observed in 9 infected mules, independently from their AGIDT reactivity. These events were generally characterised by mild, transient alterations, typical of the EIA acute form represented by hyperthermia and thrombocytopenia, in concomitance with viral RNA (vRNA) peaks that were higher in the Post-IS period, reaching values similar to those of horses during the clinical acute phase of EIA. Total tissue viral nucleic acid loads were greatest in animals with the major vRNA activity and in particular in those with negative/equivocal AGIDT reactivity. vRNA replication levels were around 10-1000 times lower than those reported in horses, with the animals still presenting typical alterations of EIA reactivation. Macroscopic lesions were absent in all the infected animals while histological alterations were characterised by lymphomonocyte infiltrates and moderate hemosiderosis in the cytoplasm of macrophages. On the basis of the above results, even mules with an equivocal/negative AGIDT reaction may act as EIAV reservoirs. Moreover, such animals could escape detection due to the low AGIDT sensitivity and therefore contribute to the maintenance and spread of the infection.


Subject(s)
Equidae , Equine Infectious Anemia/immunology , Equine Infectious Anemia/physiopathology , Immunosuppression Therapy/veterinary , Infectious Anemia Virus, Equine/immunology , Animals , Antibodies, Viral/metabolism , Antigens, Viral/metabolism , Equine Infectious Anemia/transmission , Horses , Macrophages/virology , RNA, Viral/genetics , Virus Replication
2.
Virus Res ; 128(1-2): 58-64, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17499380

ABSTRACT

In the early 1970s, the Chinese Equine Infectious Anemia Virus (EIAV) vaccine, EIAV(DLA), was developed through successive passages of a wild-type virulent virus (EIAV(L)) in donkeys in vivo and then in donkey macrophages in vitro. EIAV attenuation and cell tropism adaptation are associated with changes in both envelope and long terminal repeat (LTR). However, specific LTR changes during Chinese EIAV attenuation have not been demonstrated. In this study, we compared LTR sequences from both virulent and attenuated EIAV strains and documented the diversities of LTR sequence from in vivo and in vitro infections. We found that EIAV LTRs of virulent strains were homologous, while EIAV vaccine have variable LTRs. Interestingly, experimental inoculation of EIAV(DLA) into a horse resulted in a restriction of the LTR variation. Furthermore, LTRs from EIAV(DLA) showed higher Tat transactivated activity than LTRs from virulent strains. By using chimeric clones of wild-type LTR and vaccine LTR, the main difference of activity was mapped to the changes of R region, rather than U3 region.


Subject(s)
Genetic Variation , Horses/virology , Infectious Anemia Virus, Equine/pathogenicity , Macrophages/virology , Monocytes/virology , Promoter Regions, Genetic , Terminal Repeat Sequences/genetics , Animals , Base Sequence , Cells, Cultured , Equidae , Equine Infectious Anemia/physiopathology , Equine Infectious Anemia/virology , Gene Expression Regulation, Viral , Genes, tat , Horse Diseases/physiopathology , Horse Diseases/virology , Infectious Anemia Virus, Equine/genetics , Infectious Anemia Virus, Equine/metabolism , Molecular Sequence Data , Phylogeny , Sequence Analysis, DNA , Terminal Repeat Sequences/physiology , Transcriptional Activation , Viral Vaccines
3.
Virology ; 349(1): 22-30, 2006 May 25.
Article in English | MEDLINE | ID: mdl-16503341

ABSTRACT

Equine infectious anemia virus (EIAV) is a macrophage-tropic lentivirus that persistently infects horses and causes a disease that is characterized by periodic episodes of fever, thrombocytopenia, and viremia. EIAV encodes only four regulatory/accessory genes, (tat, rev, ttm, and S2) and is the least genetically complex of all known lentiviruses. We sought to determine the role of the EIAV S2 accessory gene of EIAV by introducing mutations that would prevent S2 expression on the p19/wenv17 infectious molecular clone. Virus derived from the p19/wenv17 molecular clone is highly virulent and routinely fatal when given in high doses (J. Virol. 72 (1998) 483). In contrast, an S2 deletion mutant on the p19/wenv17 background is unable to induce acute disease and plasma virus loads were reduced by 2.5 to 4.0 logs at 15 days post-infection. The S2 deleted virus failed to produce any detectable clinical signs during a 5-month observation period. These results demonstrate that S2 gene expression is essential for disease expression of EIAV.


Subject(s)
Equine Infectious Anemia/virology , Genes, Viral , Infectious Anemia Virus, Equine/pathogenicity , Viral Proteins/genetics , Amino Acid Sequence , Animals , Blood/virology , Body Temperature , Cell Line , Dogs , Equine Infectious Anemia/physiopathology , Gene Deletion , Genes, Essential , Horses , Infectious Anemia Virus, Equine/genetics , Macrophages/virology , Mutagenesis, Site-Directed , RNA-Directed DNA Polymerase/analysis , Sequence Homology , Viral Load , Viral Proteins/physiology , Virus Replication
4.
Arch Virol ; 151(7): 1387-403, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16502285

ABSTRACT

The Chinese equine infectious anemia virus (EIAV) donkey-leukocyte attenuated vaccine (DLV) provides a unique natural model system to study the attenuation mechanism and immunological control of lentivirus replication. Critical consensus mutations were identified between virulent Chinese EIAV strains and vaccine strains. Based on a full-length infectious clone of EIAV vaccine strain pLGFD3, two molecular clones, mFD5-4-7 and mFD7-2-11, were successfully constructed, in which 4 and 6 critical consensus mutations in the env gene of the vaccine strain were point-mutated to the wild-type sequence, respectively by an overlap PCR mutagenesis strategy. The infectivity, virulence, and pathogenesis of the constructed clones were investigated in vitro using a reverse transcriptase assay, an indirect immunofluorescence assay, observation of cytopathogenic effect, and virion observation as well as in vivo by inoculation of animals with the resulting infectious clones. The pathogenic symptoms in horses inoculated with mFD7-2-11 were more severe than those inoculated with mFD5-4-7, whereas no pathogenic symptoms were detected in animals inoculated with their parental clone pLGFD3 strain. The results indicate that the consensus mutation residues of the env region involved in this study play significant roles in the virulence and pathogenicity of EIAV. This will contribute to the elucidation of the attenuating and protective mechanisms of the Chinese EIAV vaccine.


Subject(s)
Amino Acid Substitution , Genes, env , Infectious Anemia Virus, Equine/genetics , Infectious Anemia Virus, Equine/pathogenicity , Point Mutation , Amino Acid Sequence , Animals , Body Temperature , Cell Line , Cytopathogenic Effect, Viral , Disease Models, Animal , Equidae , Equine Infectious Anemia/physiopathology , Equine Infectious Anemia/virology , Fluorescent Antibody Technique, Direct , Gene Products, env/chemistry , Gene Products, env/genetics , Horses , Microscopy, Electron, Transmission , Molecular Sequence Data , Platelet Count , Sequence Alignment , Vaccines, Attenuated/genetics , Viral Vaccines/genetics , Virulence/genetics
5.
Vaccine ; 24(6): 738-49, 2006 Feb 06.
Article in English | MEDLINE | ID: mdl-16202485

ABSTRACT

The Chinese equine infectious anemia virus (EIAV) donkey-leukocyte attenuated vaccine (DLV) provides a unique natural model system by which attenuated mechanism and immunological control of lentivirus replication may be studied. We analyzed the critical consensus mutations that occurred during the viral passages in vitro and in vivo for vaccine's preparation. Based on the full-length infectious clone pLGFD3 (EIAV vaccine background) and according to mutations displayed during viral attenuation, we successfully constructed an infectious clones pLG5-3-l in which gag and env genes were point-mutated by overlap PCR mutagenesis strategy. pLG5-3-l was proved to have the ability of effective replication in vitro cells culture systems by Reverse Transcriptase Assay and virion observation under electron microscopy. Results of the in vivo experiments indicated that marked differences occurred between the mutated virus and their parental virus in clinical manifestation and plasma viral replication during 6-month observation period. In contrast to asymptom of animals infected with pLGFD3-V, the mutated virus (pLG5-3-l-V) developed typical clinical progression in the corresponding experimentally infected animals. The results of the distinct differences in clinical profiles and viral dynamics before and after mutation of EIAV infectious clone will help to understand the protective mechanism of Chinese EIAV vaccine and shed light on novel HIV vaccine design.


Subject(s)
Amino Acid Substitution , Infectious Anemia Virus, Equine/genetics , Mutation , Viral Vaccines/chemistry , Animals , Base Sequence , Cells, Cultured , DNA Primers , Disease Progression , Equine Infectious Anemia/physiopathology , Equine Infectious Anemia/virology , Horses , Infectious Anemia Virus, Equine/pathogenicity , Reverse Transcriptase Polymerase Chain Reaction , Viral Load , Virulence
6.
J Virol ; 76(21): 10588-97, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12368301

ABSTRACT

Equine infectious anemia virus (EIAV) infection of horses is characterized by well-defined waves of viremia associated with the sequential evolution of distinct viral populations displaying extensive envelope gp90 variation; however, a correlation of in vivo envelope evolution with in vitro serum neutralization phenotype remains undefined. Therefore, the goal of the present study was to utilize a previously defined panel of natural variant EIAV envelope isolates from sequential febrile episodes to characterize the effects of envelope variation during persistent infection on viral neutralization phenotypes and to define the determinants of EIAV envelope neutralization specificity. To assess the neutralization phenotypes of the sequential EIAV envelope variants, we determined the sensitivity of five variant envelopes to neutralization by a longitudinal panel of immune serum from the source infected pony. The results indicated that the evolution of the EIAV envelope sequences observed during sequential febrile episodes produced an increasingly neutralization-resistant phenotype. To further define the envelope determinants of EIAV neutralization specificity, we examined the neutralization properties of a panel of chimeric envelope constructs derived from reciprocal envelope domain exchanges between selected neutralization-sensitive and neutralization-resistant envelope variants. These results indicated that the EIAV gp90 V3 and V4 domains individually conferred serum neutralization resistance while other envelope segments in addition to V3 and V4 were evidently required for conferring total serum neutralization sensitivity. These data clearly demonstrate for the first time the influence of sequential gp90 variation during persistent infection in increasing envelope neutralization resistance, identify the gp90 V3 and V4 domains as the principal determinants of antibody neutralization resistance, and indicate distinct complex cooperative envelope domain interactions in defining sensitivity to serum antibody neutralization.


Subject(s)
Epitopes, B-Lymphocyte/immunology , Glycoproteins/immunology , Immunodominant Epitopes/immunology , Infectious Anemia Virus, Equine/immunology , Viral Envelope Proteins/immunology , Amino Acid Sequence , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Directed Molecular Evolution , Disease Progression , Epitope Mapping , Epitopes, B-Lymphocyte/genetics , Equine Infectious Anemia/physiopathology , Equine Infectious Anemia/virology , Glycoproteins/genetics , Horses , Immunodominant Epitopes/genetics , Infectious Anemia Virus, Equine/genetics , Molecular Sequence Data , Neutralization Tests , Phenotype , Viral Envelope Proteins/genetics
7.
J Virol ; 75(10): 4570-83, 2001 May.
Article in English | MEDLINE | ID: mdl-11312327

ABSTRACT

A primary mechanism of lentivirus persistence is the ability of these viruses to evolve in response to biological and immunological selective pressures with a remarkable array of genetic and antigenic variations that constitute a perpetual natural experiment in genetic engineering. A widely accepted paradigm of lentivirus evolution is that the rate of genetic variation is correlated directly with the levels of virus replication: the greater the viral replication, the more opportunities that exist for genetic modifications and selection of viral variants. To test this hypothesis directly, we examined the patterns of equine infectious anemia virus (EIAV) envelope variation during a 2.5-year period in experimentally infected ponies that differed markedly in clinical progression and in steady-state levels of viral replication as indicated by plasma virus genomic RNA assays. The results of these comprehensive studies revealed for the first time similar extents of envelope gp90 variation in persistently infected ponies regardless of the number of disease cycles (one to six) and viremia during chronic disease. The extent of envelope variation was also independent of the apparent steady-state levels of virus replication during long-term asymptomatic infection, varying from undetectable to 10(5) genomic RNA copies per ml of plasma. In addition, the data confirmed the evolution of distinct virus populations (genomic quasispecies) associated with sequential febrile episodes during acute and chronic EIA and demonstrated for the first time ongoing envelope variation during long-term asymptomatic infections. Finally, comparison of the rates of evolution of the previously defined EIAV gp90 variable domains demonstrated distinct differences in the rates of nucleotide and amino acid sequence variation, presumably reflecting differences in the ability of different envelope domains to respond to immune or other biological selection pressures. Thus, these data suggest that EIAV variation can be associated predominantly with ongoing low levels of virus replication and selection in target tissues, even in the absence of substantial levels of plasma viremia, and that envelope variation continues during all stages of persistent infection as the virus successfully avoids clearance by host defense mechanisms.


Subject(s)
Evolution, Molecular , Genome, Viral , Glycoproteins/genetics , Infectious Anemia Virus, Equine/genetics , Viral Envelope Proteins/genetics , Acute Disease , Amino Acid Sequence , Animals , Base Sequence , Chronic Disease , DNA, Viral , Disease Progression , Equine Infectious Anemia/physiopathology , Equine Infectious Anemia/virology , Genetic Variation , Glycoproteins/classification , Horses , Infectious Anemia Virus, Equine/classification , Molecular Sequence Data , Phylogeny , Sequence Homology, Amino Acid , Time Factors , Viral Envelope Proteins/classification , Viremia/virology
8.
Virology ; 279(1): 185-200, 2001 Jan 05.
Article in English | MEDLINE | ID: mdl-11145901

ABSTRACT

Genetic and biological variation in the regulatory protein Rev of equine infectious anemia virus (EIAV) were examined throughout a clinically dynamic disease course of an experimentally infected pony. Following infection with the virulent EIAV(Wyo), the pony underwent a variable disease course, including an acute fever episode at 12 days postinfection (DPI), multiple recurrent fever episodes until 135 DPI, a prolonged subclinical period, and two late fever episodes. Viral RNA was isolated from the inoculum and sequential sera samples, and the rev exon 2/gp45 overlapping ORFs were amplified, cloned, and sequenced. Novel variants were found throughout infection, and genetic analyses indicated that both the Rev and gp45 ORFs were under selective pressure. The Rev variant predominant in the inoculum, R1, remained predominant during the early periods following infection (until 35 DPI); however, R1 was replaced by new predominant variants during the recurrent fever period (67-135 DPI). R1 reemerged as the predominant variant during the afebrile period, but a new predominant variant, R93, was associated with the late fever episodes. Rev variants predominant during recurrent febrile and late-febrile periods had significantly higher Rev-mediated nuclear export activity than the variants predominant during the acute and afebrile periods. Statistical correlation was found between Rev activity and different stages of clinical disease. Together, these results suggest that genetic and biological variation in rev may be a contributing factor in EIAV disease progression.


Subject(s)
Equine Infectious Anemia/physiopathology , Gene Products, rev/genetics , Gene Products, rev/metabolism , Infectious Anemia Virus, Equine/genetics , Infectious Anemia Virus, Equine/pathogenicity , Amino Acid Sequence , Animals , Equine Infectious Anemia/virology , Evolution, Molecular , Gene Products, rev/chemistry , Genetic Variation , Horses , Infectious Anemia Virus, Equine/classification , Infectious Anemia Virus, Equine/physiology , Molecular Sequence Data , RNA, Viral/blood , Sequence Analysis, DNA , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Load , Virulence
9.
J Virol ; 74(13): 5968-81, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10846078

ABSTRACT

Persistent infection of equids by equine infectious anemia virus (EIAV) is typically characterized by a progression during the first year postinfection from chronic disease with recurring disease cycles to a long-term asymptomatic infection that is maintained indefinitely. The goal of the current study was to perform a comprehensive longitudinal analysis of the course of virus infection and development of host immunity in experimentally infected horses as they progressed from chronic disease to long-term inapparent carriage. We previously described the evolution of EIAV genomic quasispecies (C. Leroux, C. J. Issel, and R. C. Montelaro, J. Virol. 71:9627-9639, 1997) and host immune responses (S. A. Hammond, S. J. Cook, D. L. Lichtenstein, C. J. Issel, and R. C. Montelaro, J. Virol. 71:3840-3852, 1997) in four experimentally infected ponies during sequential disease episodes associated with chronic disease during the first 10 months postinfection. In the current study, we extended the studies of these experimentally infected ponies to 3 years postinfection to characterize the levels of virus replication and development of host immune responses associated with the progression from chronic disease to long-term inapparent infection. The results of these studies revealed over a 10(3)-fold difference in the steady-state levels of plasma viral RNA detected during long-term inapparent infection that correlated with the severity of chronic disease, indicating different levels of control of virus replication during long-term inapparent infections. Detailed analyses of antibody and cellular immune responses in all four ponies over the 3-year course of infection revealed a similar evolution during the first year postinfection of robust humoral and cellular immunity that then remained relatively constant during long-term inapparent infection. These observations indicate that immune parameters that have previously been correlated with EIAV vaccine protection fail to provide reliable immune correlates of control of virus replication or clinical outcome in experimental infections. Thus, these data emphasize the differences between immunity to virus exposure and immune control of an established viral infection and further emphasize the need to develop and evaluate novel immunoassays to define reliable immune correlates to vaccine and infection immunity, respectively.


Subject(s)
Equine Infectious Anemia/immunology , Equine Infectious Anemia/virology , Virus Replication/immunology , Animals , Antibodies, Viral/blood , Antibodies, Viral/immunology , Antibody Affinity , Equine Infectious Anemia/physiopathology , Horses , Infectious Anemia Virus, Equine/genetics , Infectious Anemia Virus, Equine/immunology , Infectious Anemia Virus, Equine/physiology , Neutralization Tests , RNA, Viral/blood , Reverse Transcriptase Polymerase Chain Reaction/methods , T-Lymphocytes, Cytotoxic/immunology , Time Factors , Viral Envelope Proteins/immunology
10.
J Virol ; 71(12): 9627-39, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9371627

ABSTRACT

We have investigated the genetic evolution of three functionally distinct regions of the equine infectious anemia virus (EIAV) genome (env, rev, and long terminal repeat) during recurring febrile episodes in a pony experimentally infected with a well-characterized reference biological clone designated EIAV(PV). Viral populations present in the plasma of an EIAV(PV)-infected pony during sequential febrile episodes (18, 34, 80, 106, and 337 days postinfection) were amplified from viral RNA, analyzed, and compared to the inoculated strain. The comparison of the viral quasispecies showed that the inoculated EIAV(PV) quasispecies were all represented during the first febrile episode, but entirely replaced at the time of the second febrile episode, and that new predominant quasispecies were associated with each subsequent cycle of disease. One of the more surprising results was the in vivo generation of large deletion (up to 15 amino acids) in the principal neutralizing domain (PND) of gp90 during the third febrile episode. This deletion did not alter the competence for in vitro replication as shown by the analysis of a env chimeric clone with a partially deleted PND and did not altered the fitness of the virus in vivo, since this partially deleted envelope became the major population during the fourth febrile episode. Finally, we showed that the amino acid mutations were not randomly distributed but delineated eight variables regions, V1 to V8, with V3 containing the PND region. These studies provide the first detailed description of the evolution of EIAV genomic quasispecies during persistent infection and reveal new insights into the genetics and potential mechanisms of lentivirus genomic variation.


Subject(s)
Equine Infectious Anemia/virology , Genes, rev , Genome, Viral , Glycoproteins/genetics , Infectious Anemia Virus, Equine/genetics , Repetitive Sequences, Nucleic Acid , Viral Envelope Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , DNA, Viral , Equine Infectious Anemia/physiopathology , Evolution, Molecular , Genetic Variation , Horses , Infectious Anemia Virus, Equine/physiology , Molecular Sequence Data , Neutralization Tests , Sequence Deletion , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid , Virus Replication
11.
J Virol ; 70(11): 7842-50, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8892906

ABSTRACT

The purpose of this study was to identify the mechanisms responsible for the thrombocytopenia that develops following infection of horses by the lentivirus equine infectious anemia virus (EIAV). Immunocompetent Arabian foals and Arabian foals with severe combined immunodeficiency (SCID), which lack functional B and T lymphocytes, were experimentally infected with EIAV. Levels of viremia and a number of clinical and hematologic parameters were examined prior to and following infection. Thrombocytopenia was not dependent on the immune response: SCID foals were affected as severely as immunocompetent foals. Production of platelets, measured by metabolic incorporation of radioactive label, was significantly reduced. The decrease ranged from 35 to 89% in three SCID and two immunocompetent foals examined. Platelet survival, measured by 51Cr labeling, also declined following infection in both SCID and immunocompetent foals: 51 and 68%, respectively, relative to the preinfection life spans. The difference between immunocompetent and immunodeficient foals was not statistically significant. The number of megakaryocytes (MK) per square millimeter of bone marrow, determined by digitizing morphometry, was not significantly altered in either SCID or immunocompetent thrombocytopenic foals. Numbers of denuded MK nuclei per unit area increased, but the elevation was not statistically significant. No evidence for viral replication in MK was found. Three different parameters of intravascular coagulation (activated prothombin time, fibrin degradation products, and one-step prothombin time) remained normal until after platelet numbers had declined significantly, arguing against an important role for disseminated intravascular coagulation. The findings indicate that EIAV induces thrombocytopenia principally through an indirect, noncytocidal suppressive effect on platelet production, the mechanism of which is unknown. A shortening of platelet life span apparently contributes moderately to the platelet deficit as well. The shortening of platelet life span is multifactorial in origin, including both mechanisms that depend on an active immune response and those that do not.


Subject(s)
Equine Infectious Anemia/blood , Platelet Count , Thrombocytopenia/veterinary , Animals , Antigens, Viral/analysis , Blood Coagulation Factors , Blood Platelets/physiology , Blood Platelets/ultrastructure , Bone Marrow Cells , Equidae , Equine Infectious Anemia/physiopathology , Equine Infectious Anemia/virology , Infectious Anemia Virus, Equine/growth & development , Infectious Anemia Virus, Equine/immunology , Megakaryocytes/ultrastructure , Severe Combined Immunodeficiency , Thrombocytopenia/physiopathology , Viremia
13.
Cornell Vet ; 68(2): 238-49, 1978 Apr.
Article in English | MEDLINE | ID: mdl-639520

ABSTRACT

Neurologic signs and neuropathologic lesions associated with a case of equine infectious anemia in a 7 year old Quarter-horse mare were studied. Clinical signs included depression, disorientation, circling, knuckling at the fetlock and hypermetria. The neuropathologic lesions were characterized by a granulomatous ependymitis, subependymal encephalitis, choroiditis and hydrocephalus. These lesions were associated with signs of neurologic dysfunction which were the cause of the prominent clinical features.


Subject(s)
Brain/pathology , Equine Infectious Anemia/pathology , Animals , Equine Infectious Anemia/physiopathology , Female , Horses , Kidney/pathology , Liver/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...